In Field-Stimulated Guinea-Pig Atria an AT1-Receptor Mediated Increase of Noradrenaline Release by Angiotensin II is Seen only in the Presence of Prejunctional Autoinhibition
The octapeptide angiotensin II is a potent vasoconstrictor and increases the release of adrenaline from the adrenal medulla and noradrenaline from the terminal reticulum of sympathetic nerves. The main source of angiotensin II in plasma is angiotensinogen, which is metabolized to angiotensin I by renin secreted from the kidneys and then to the active compound angiotensin II by a circulating angiotensin converting enzyme. There is increasing evidence, however, that angiotensin II can also be produced locally in a variety of tissues. In the heart angiotensin I, II and III are present and a messenger RNA for the synthesis of renin as well as a tissue-bound converting enzyme have been detected (Lindpainter et al. 1987). This local renin-angiotensin system seems to be involved in the regulation of cell growth and may be an important factor for the development of cardiac hypertrophy (Linz et al. 1989). It can also participate in the local control of the sympathetic tone by an activation of prejunctional angiotensin receptors on nerve terminals (Ziogas et al. 1984).
KeywordsRefractory Period Electrical Field Pulse Field Pulse Noradrenaline Release Stimulation Period
Unable to display preview. Download preview PDF.
- Lindpainter K, Wilhelm MJ, Jin M, Unger T, Lang RE, Schölkens BA, Ganten D. Tissue renin-angiotensin system: focus on the heart. J Hypertens 1987; 5 (Suppl. 2): 533–538.Google Scholar